| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/02/1994 | US5334717 Inhibit lentiviruses |
| 08/02/1994 | US5334716 Preventing testosteron 5a-reductase mediated diseases; alopecia, acne, prostatism |
| 08/02/1994 | US5334715 For treating psychological disorders |
| 08/02/1994 | US5334711 Synthetic catalytic oligonucleotide structures |
| 08/02/1994 | US5334706 Administration of low dose hemoglobin to increase perfusion |
| 08/02/1994 | US5334618 Administering amantadine or derivative |
| 08/02/1994 | US5334617 Preventing food spoilage and animal protein aging |
| 08/02/1994 | US5334615 Oil with bactericidal and virucidal properties |
| 08/02/1994 | US5334614 Lipoxygenase inhibitor |
| 08/02/1994 | US5334612 Solid, semisolid, solution, suspension or emulsion dosage unit |
| 08/02/1994 | US5334610 α-aryl-α-hydroxy-β-imidazolinyl-propionamides |
| 08/02/1994 | US5334608 Azolymethyl-cyclopropyl derivatives |
| 08/02/1994 | US5334607 Methods for treating mycoses |
| 08/02/1994 | US5334606 Oxazolidindione substituted indole derivatives |
| 08/02/1994 | US5334604 Administering to mammals to lower glucose and/or cholesterol in the blood |
| 08/02/1994 | US5334602 Antiarrhytmic agent |
| 08/02/1994 | US5334597 Indole carbamates as leukotriene antagonists |
| 08/02/1994 | US5334596 Anticoagulants |
| 08/02/1994 | US5334594 Antihistamines, antiallergens |
| 08/02/1994 | US5334593 Anxiolytic drugs |
| 08/02/1994 | US5334592 Administering for allergic reactions; thienotriazolodiazepine compounds |
| 08/02/1994 | US5334591 Useful in the treatment of ocular hypertension and glaucoma |
| 08/02/1994 | US5334589 Bactericides for treating infections; stability, side-effect reduction |
| 08/02/1994 | US5334588 Composition for inhibiting transmission of hepatitis B virus |
| 08/02/1994 | US5334587 For adverse reactions from cancer chemotherapy, infections, cerebral dysfunction or fungal infection |
| 08/02/1994 | US5334393 Isosorbide 5-mononitrate powder with specified particle size profile homogeneously dispersed in hydrophilic matrix of swelling agent and diluent |
| 08/02/1994 | US5334392 Hypotensive agents |
| 08/02/1994 | US5334385 New alkaloid derivatives, their use and pharmaceutical formulations containing them |
| 08/02/1994 | US5334380 Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension |
| 08/02/1994 | US5334375 Antibacterial antiplaque oral composition |
| 08/02/1994 | US5334374 Treating pneumo-cystis carinii pneumonia(PCP), common with AIDS, cancer and organ transplant patients |
| 08/02/1994 | US5334369 Platelet receptor antagonists useful in detecting intravascular platelet aggregation |
| 08/02/1994 | US5334138 Drug delivery; mixture of active material and vasoconstrictor |
| 08/02/1994 | CA1331197C Enantiomeric glutaramide diuretic agents |
| 08/02/1994 | CA1331196C Use of retinoids |
| 08/02/1994 | CA1331191C Therapeutically useful tetralin derivatives |
| 08/02/1994 | CA1331186C Valproic and (e)-2-valproenoic acid derivatives, processes for the preparation thereof and pharmaceutical compositions therefrom |
| 08/02/1994 | CA1331178C Triazolo ¬1,5-c| pyrimido ¬1,4| azines as bronchodilators |
| 08/02/1994 | CA1331177C 3-oxo-1,2,4-triazolo¬4,3-a|pyrimidine-6-carboxylic acid esters |
| 08/02/1994 | CA1331140C Agents for preserving or restoring the soundness of the skin |
| 08/02/1994 | CA1331139C Medicaments for the treatment of cerebral apoplexy |
| 08/02/1994 | CA1331138C Use of reverse transcriptase inhibitor for treatment of human breast carcinoma |
| 08/02/1994 | CA1331137C Transdermal flux enhancing compositions |
| 08/02/1994 | CA1331136C Stable mixture containing oxidation-sensitive compounds, preparation thereof and use of a combination of substances for stabilizing oxidation-sensitive compounds |
| 08/02/1994 | CA1331130C Use of the enzyme cofactor nadph for the preparation of a medicament as well as a medicament prepared therefrom and a process for its preparation |
| 07/30/1994 | CA2114450A1 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses |
| 07/30/1994 | CA2114361A1 Piperazine derivatives |
| 07/30/1994 | CA2114359A1 Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents |
| 07/30/1994 | CA2114355A1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| 07/30/1994 | CA2113787A1 Carbocyclic sulfonamides |
| 07/29/1994 | WO1994017069A1 Pyrazole derivatives and pharmaceutical compositions thereof |
| 07/29/1994 | CA2151930A1 Pyrazole derivatives and pharmaceutical compositions thereof |
| 07/29/1994 | CA2114333A1 Tyrosine kinase inhibitors and benzoylacrylamide derivatives |
| 07/28/1994 | DE4309217A1 Combination product of pantothenic acid or dexpanthenol + alpha -lipoic acid + vitamin E (muscular dystrophy, polyneuropathy, muscle atrophy, ataxia, new indication ( alpha -lipoic acid + pantothenic acid) Alzheimer's disease |
| 07/28/1994 | DE4301739A1 Treatment of primary tumours and viral diseases |
| 07/28/1994 | DE4301465A1 Combination product especially for muscular dystrophy, but also treatment of polyneuropathy, MS, ataxia, muscle atrophy etc. with the combinations |
| 07/28/1994 | CA2114422A1 Triglycerides (ii) |
| 07/28/1994 | CA2114421A1 Triglycerides |
| 07/27/1994 | EP0608207A1 Nanocapsule containing pharmaceutical compositions |
| 07/27/1994 | EP0608172A1 Phaffia rhodozyma mutants, process for the production of beta-caroten and use of a beta-caroten rich biomass |
| 07/27/1994 | EP0608111A1 Isolation and structure of spongistatin 1 and its use as an anti-tumor agent |
| 07/27/1994 | EP0608110A1 Isolation and structure of halistatin 2, and its use as an anti-tumor agent |
| 07/27/1994 | EP0608109A1 Isolation and structural elucidation of cephalostatin 7, 8 and 9, and their use as anti-tumor agents |
| 07/27/1994 | EP0608108A1 Isolation and structure of halistatin 1, and its use as an anti-tumor agent |
| 07/27/1994 | EP0608058A1 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent |
| 07/27/1994 | EP0608002A1 Optically active compounds |
| 07/27/1994 | EP0607825A1 6-H-4-OXO-3-quinoline-carboxylic acids and their analogues as antibacterial agents |
| 07/27/1994 | EP0607822A1 Formulation for testing the vitality of teeth containing liquid propellants |
| 07/27/1994 | EP0607777A2 Use of leflunomid for the inhibition of interleukin 8 |
| 07/27/1994 | EP0607776A2 Use of leflunomid for the inhibition of tumor necrosis factor alpha |
| 07/27/1994 | EP0607775A2 Use of leflunomid for the inhibition of interleukin 1 beta |
| 07/27/1994 | EP0607774A2 Use of leflunomid for the inhibition of interleukin 1 alpha |
| 07/27/1994 | EP0607697A2 DILAZEP for reduction of elevated intraocular pressure |
| 07/27/1994 | EP0607647A1 N-Methyldeacetylcolchiceinamide derivatives |
| 07/27/1994 | EP0607642A1 Compositions for topical application to the skin for treatment and/or prevention of radiation-induced skin damage |
| 07/27/1994 | EP0607467A1 Compositions containing S(+)-Ibuprofen |
| 07/27/1994 | EP0607439A1 Nitrogenous heterocyclic compound |
| 07/27/1994 | EP0607434A1 Anti-inflammatory analgesic plaster |
| 07/27/1994 | EP0607413A1 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
| 07/27/1994 | EP0607400A1 Fluorinated 17-beta substituted-4-aza-5-alpha- andostran-3one derivatives. |
| 07/27/1994 | EP0607374A1 Novel cyclic lipid derivatives as potent paf antagonists |
| 07/27/1994 | EP0607367A1 Novel adenosine derivatives |
| 07/27/1994 | EP0607355A1 3-ureido-benzodiazepinones useful as antagonists of cck or of gastrine. |
| 07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/27/1994 | EP0607344A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 07/27/1994 | EP0607334A1 Cyclic ureas and analogues useful as retroviral protease inhibitiors. |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607329A1 New derivatives of fluoro-quinoline carboxylic-3 acid and preparation thereof |
| 07/27/1994 | EP0607296A1 Use of misoprostol for the treatment of late-phase allergy |
| 07/27/1994 | EP0607282A1 New use of substituted quinoline carboxamide |
| 07/27/1994 | EP0607278A1 Method for enhancing gut absorption |
| 07/27/1994 | EP0607252A1 Method of treating hiv infection |
| 07/27/1994 | EP0607245A1 Cholesterol lowering compounds and process for making them |
| 07/27/1994 | EP0607233A1 3,9-diazabicyclo(3.3.1)nonane derivatives with 5-ht3 receptor antagonist activity |
| 07/27/1994 | EP0607222A1 Dendrimeric polychelants |
| 07/27/1994 | EP0607217A1 Pyridinol derivatives as medicaments |
| 07/27/1994 | EP0607201A1 Composition comprising s-oxiracetame for use as nootropic |
| 07/27/1994 | EP0607198A1 Preparation of improved alkylpolyglycoside surfactant mixtures |
| 07/27/1994 | EP0607193A1 Triazole antifungal agents |
| 07/27/1994 | EP0607178A1 Methods for the selection, separation and fusion of cells |